Consumer Mitochondrial Testing Goes Mainstream

A new wave of companies (ex: Mitome) is offering direct‑to‑consumer mitochondrial and metabolic analyses aimed at identifying 'energy bottlenecks' that purportedly underlie chronic disease and performance limits. These services blend genomic, metabolic and lifestyle data and are being promoted by scientist‑founders who publicly critique mainstream public‑health narratives. — If adopted widely, consumer mitochondrial testing could shift preventive medicine toward individualized metabolic monitoring, raise questions about evidence standards, regulatory oversight, and the privatization of biomedical knowledge.